Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TEXAS INSTRUMENTS INC Director's Dealing 2022

Feb 8, 2022

29799_dirs_2022-02-08_8351b96b-ca05-4dc5-847c-cbd38218193b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TEXAS INSTRUMENTS INC (TXN)
CIK: 0000097476
Period of Report: 2022-02-04

Reporting Person: BLINN MARK A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-04 Common Stock M 1077 $110.15 Acquired 14140 Direct
2022-02-04 Common Stock M 1133 $104.41 Acquired 15273 Direct
2022-02-04 Common Stock M 978 $130.52 Acquired 16251 Direct
2022-02-04 Common Stock S 464 $168.1639 Disposed 15787 Direct
2022-02-04 Common Stock S 845 $169.1867 Disposed 14942 Direct
2022-02-04 Common Stock S 635 $170.4414 Disposed 14307 Direct
2022-02-04 Common Stock S 1650 $171.4026 Disposed 12657 Direct
2022-02-04 Common Stock S 501 $172.3225 Disposed 12156 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-02-04 NQ Stock Option (Right to Buy) $110.15 M 1077 Disposed 2028-01-25 Common Stock (1077) Direct
2022-02-04 NQ Stock Option (Right to Buy) $104.41 M 1133 Disposed 2029-01-25 Common Stock (1133) Direct
2022-02-04 NQ Stock Option (Right to Buy) $130.52 M 978 Disposed 2030-01-24 Common Stock (978) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5400 Indirect
Common Stock 5400 Indirect
Common Stock 3046 Indirect
Common Stock 1200 Indirect

Footnotes

F1: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $167.65 to $168.48. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F2: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $168.775 to $169.69. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F3: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $169.985 to $170.915. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F4: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $171.01 to $171.89. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F5: The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $172.055 to $172.68. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

F6: Shares held in Trust for the benefit of family member of which reporting person is trustee. Beneficial ownership by reporting person disclaimed.

F7: Shares held in Trust for the benefit of the reporting person. Reporting person is the sole trustee.

F8: Shares held in Trust for the benefit of family member; reporting person shares investment control. Beneficial ownership by reporting person disclaimed.

F9: Shares held in Trust for the benefit of family member of which reporting person is a co-trustee. Beneficial ownership by reporting person disclaimed.

F10: The option became exercisable in four equal annual installments beginning on January 25, 2019.

F11: The option became exercisable in four equal annual installments beginning on January 25, 2020.

F12: The option became exercisable in four equal annual installments beginning on January 24, 2021.